Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
6
×
life sciences
national blog main
boston blog main
rna interference
alnylam pharmaceuticals
biotech
boston
boston top stories
drugs
aminolevulinic acid
fda
givosiran
national top stories
new york blog main
new york top stories
patisiran
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
accelerated approval
acute hepatic porphyria
acute hepatic porphyrias
akcea therapeutics
akin akinc
alexion pharmaceuticals
alirocumab
alnylam
alnylam pharmaceutials
amgen
arena pharmaceuticals
arrowhead pharmaceuticals
artie suckow
barry greene
boehringer ingelheim
boston university
dan ollendorf
deals
What
rna
6
×
alnylam
ago
drug
interference
medicine
medicines
new
pharmaceuticals
rnai
data
fda
long
pharma
second
seek
small
speedy
abandoning
advance
approval
approve
awaits
baggage
based
biological
biologics
cholesterol
cleared
companies
considered
crossed
cuts
deal
decades
decision
deliver
development
dicerna
discovered
Language
unset
Current search:
rna
×
" clinical trials "
×
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision